TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138
   PubMed Web of Science ®Google Scholar
• Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, et al. Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol 1999; 10 1:87-92; PMID:10219460; http://dx.doi.org/10.1023/A:1008323922057
   PubMedGoogle Scholar
• Raja FA, Counsell N, Colombo N, Pfisterer J, du Bois A, Parmar MK, Vergote IB, Gonzalez-Martin A, Alberts DS, Plante M, et al. Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data. Ann Oncol 2013; 24:3028-34; PMID:24190964; http://dx.doi.org/10.1093/annonc/mdt406
   PubMed Web of Science ®Google Scholar
• Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc 2007; 82:751-70; PMID:17550756; http://dx.doi.org/10.1016/S0025-6196(11)61196-8
   PubMedGoogle Scholar
• Hall M, Gourley C, McNeish I, Ledermann J, Gore M, Jayson G, Perren T, Rustin G, Kaye S. Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer 2013; 108:250-8; PMID:23385789; http://dx.doi.org/10.1038/bjc.2012.541
   PubMed Web of Science ®Google Scholar
• Morgan RJ, Jr., Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, et al. Ovarian cancer, version 3.2012. J Natl Compr Canc Netw 2012; 10:1339-49; PMID:23138163.
   PubMed Web of Science ®Google Scholar
• Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of taxol resistance related to microtubules. Oncogene 2003; 22:7280-95; PMID:14576838; http://dx.doi.org/10.1038/sj.onc.1206934
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res 2009; 69:3918-26; PMID:19383919; http://dx.doi.org/10.1158/0008-5472.CAN-08-2747
   PubMed Web of Science ®Google Scholar
• Bhalla KN. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003; 22:9075-86; PMID:14663486; http://dx.doi.org/10.1038/sj.onc.1207233
   PubMed Web of Science ®Google Scholar
• Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011; 471:110-4; PMID:21368834; http://dx.doi.org/10.1038/nature09779
   PubMed Web of Science ®Google Scholar
• Drukman S, Kavallaris M. Microtubule alterations and resistance to tubulin-binding agents (review). Int J Oncol 2002; 21:621-8; PMID:12168109.
   PubMed Web of Science ®Google Scholar
• Fu Y, Ye D, Chen H, Lu W, Ye F, Xie X. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30. Gynecol Oncol 2007; 105:66-73; PMID:17234259; http://dx.doi.org/10.1016/j.ygyno.2006.10.061
   PubMed Web of Science ®Google Scholar
• Jeong W, Yoon HW, Lee SR, Rhee SG. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. new insights into the specificity of thioredoxin function. J Biol Chem 2004; 279:3142-50; PMID:14607844; http://dx.doi.org/10.1074/jbc.M307932200
   PubMed Web of Science ®Google Scholar
• Jeong W, Chang TS, Boja ES, Fales HM, Rhee SG. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-α signaling pathways. J Biol Chem 2004; 279:3151-9; PMID:14607843; http://dx.doi.org/10.1074/jbc.M307959200
   PubMed Web of Science ®Google Scholar
• Harris J. Autophagy and cytokines. Cytokine 2011; 56:140-4; PMID:21889357; http://dx.doi.org/10.1016/j.cyto.2011.08.022
   PubMed Web of Science ®Google Scholar
• Liu F, Liu D, Yang Y, Zhao S. Effect of autophagy inhibition on chemotherapy-induced apoptosis in A549 lung cancer cells. Oncol Lett 2013; 5:1261-5; PMID:23599776.
   PubMed Web of Science ®Google Scholar
• Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y, Yuan H. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 2011; 307:141-8; PMID:21511395; http://dx.doi.org/10.1016/j.canlet.2011.03.026
   PubMed Web of Science ®Google Scholar
• Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2011; 11:157-68; PMID:21228626; http://dx.doi.org/10.4161/cbt.11.2.14622
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910-814
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51-64; PMID:16843265; http://dx.doi.org/10.1016/j.ccr.2006.06.001
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8:741-52; PMID:17717517; http://dx.doi.org/10.1038/nrm2239
   PubMed Web of Science ®Google Scholar
• Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 2005; 24:980-91; PMID:15592527; http://dx.doi.org/10.1038/sj.onc.1208095
   PubMed Web of Science ®Google Scholar
• Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 2004; 101:18030-5; PMID:15596714; http://dx.doi.org/10.1073/pnas.0408345102
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Cregg JM, Dunn WA, Jr., Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell 2003; 5:539-45; PMID:14536056; http://dx.doi.org/10.1016/S1534-5807(03)00296-X
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Lee DH, Chung K, Song JA, Kim TH, Kang H, Huh JH, Jung SG, Ko JJ, An HJ. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells. J Proteome Res 2010; 9:5668-76; PMID:20858016; http://dx.doi.org/10.1021/pr100478u
   PubMed Web of Science ®Google Scholar
• Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB, Rotilio D. A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 2009; 1794:225-36; PMID:18973835; http://dx.doi.org/10.1016/j.bbapap.2008.09.017
   PubMedGoogle Scholar
• Pan S, Cheng L, White JT, Lu W, Utleg AG, Yan X, Urban ND, Drescher CW, Hood L, Lin B. Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. OMICS 2009; 13:345-54; PMID:19422301; http://dx.doi.org/10.1089/omi.2009.0008
   PubMed Web of Science ®Google Scholar
• Jeong W, Jung Y, Kim H, Park SJ, Rhee SG. Thioredoxin-related protein 14, a new member of the thioredoxin family with disulfide reductase activity: implication in the redox regulation of TNF-α signaling. Free Radic Biol Med 2009; 47:1294-303; PMID:19628032; http://dx.doi.org/10.1016/j.freeradbiomed.2009.07.021
   PubMedGoogle Scholar
• Lin HX, Qiu HJ, Zeng F, Rao HL, Yang GF, Kung HF, Zhu XF, Zeng YX, Cai MY, Xie D. Decreased expression of beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One 2013; 8:e60516; PMID:23573264; 10.1371/journal.pone.0060516
   PubMedGoogle Scholar
• May T, Shoni M, Crum CP, Xian W, Vathipadiekal V, Birrer M, Rosen B, Tone A, Murphy KJ. Low-grade and high-grade serous mullerian carcinoma: review and analysis of publicly available gene expression profiles. Gynecol Oncol 2013; 128:488-92; PMID:23253401; http://dx.doi.org/10.1016/j.ygyno.2012.12.009
   PubMedGoogle Scholar
• Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, Yoo NJ, Lee SH. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007; 115:1344-9; PMID:18184403; http://dx.doi.org/10.1111/j.1600-0463.2007.00858.x
   PubMed Web of Science ®Google Scholar
• Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, Zhu XF, Zhang XS. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009; 5:303-6; PMID:19066461; http://dx.doi.org/10.4161/auto.5.3.7491
   PubMed Web of Science ®Google Scholar
• Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14:90-102; PMID:18598947; http://dx.doi.org/10.1016/j.ccr.2008.06.004
   PubMed Web of Science ®Google Scholar
• Gorka M, Daniewski WM, Gajkowska B, Lusakowska E, Godlewski MM, Motyl T. Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel. Anticancer Drugs 2005; 16:777-88; PMID:16027528; http://dx.doi.org/10.1097/01.cad.0000171514.50310.85
   PubMedGoogle Scholar
• Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 2007; 14:548-58; PMID:16946731; http://dx.doi.org/10.1038/sj.cdd.4402030
   PubMed Web of Science ®Google Scholar
• Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007; 110:313-22; PMID:17363733; http://dx.doi.org/10.1182/blood-2006-10-050260
   PubMed Web of Science ®Google Scholar
• O'Donovan TR, O'Sullivan GC, McKenna SL. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 2011; 7:509-24; PMID:21325880; http://dx.doi.org/10.4161/auto.7.5.15066
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011; 10:1533-41; PMID:21878654; http://dx.doi.org/10.1158/1535-7163.MCT-11-0047
   PubMed Web of Science ®Google Scholar
• Veldhoen RA, Banman SL, Hemmerling DR, Odsen R, Simmen T, Simmonds AJ, Underhill DA, Goping IS. The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis. Oncogene 2013; 32:736-46; PMID:22430212; http://dx.doi.org/10.1038/onc.2012.92
   PubMed Web of Science ®Google Scholar
• Yue Z, Zhong Y. From a global view to focused examination: understanding cellular function of lipid kinase VPS34-Beclin 1 complex in autophagy. J Mol Cell Biol 2010; 2:305-7; PMID:20846953; http://dx.doi.org/10.1093/jmcb/mjq028
   PubMed Web of Science ®Google Scholar
• Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M, Vandenabeele P. Beclin1: a role in membrane dynamics and beyond. Autophagy 2012; 8:6-17; PMID:22170155; http://dx.doi.org/10.4161/auto.8.1.16645
   PubMed Web of Science ®Google Scholar
• Jung Y, Kim H, Min SH, Rhee SG, Jeong W. Dynein light chain LC8 negatively regulates NF-kappaB through the redox-dependent interaction with ikappabalpha. J Biol Chem 2008; 283:23863-71; PMID:18579519; http://dx.doi.org/10.1074/jbc.M803072200
   PubMed Web of Science ®Google Scholar
• Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 2009; 29:2594-608; PMID:19289499; http://dx.doi.org/10.1128/MCB.01396-08
   PubMed Web of Science ®Google Scholar
• Shi MF, Jiao J, Lu WG, Ye F, Ma D, Dong QG, Xie X. Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci 2010; 67:3915-25; PMID:20549538; http://dx.doi.org/10.1007/s00018-010-0420-9
   PubMedGoogle Scholar
• Fu Y, Hu D, Qiu J, Xie X, Ye F, Lu WG. Overexpression of glycogen synthase kinase-3 in ovarian carcinoma cells with acquired paclitaxel resistance. Int J Gynecol Cancer 2011; 21:439-44; PMID:21436692; http://dx.doi.org/10.1097/IGC.0b013e31820d7366
   PubMed Web of Science ®Google Scholar
• Mo QQ, Chen PB, Jin X, Chen Q, Tang L, Wang BB, Li KZ, Wu P, Fang Y, Wang SX, et al. Inhibition of hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel. Acta Pharmacol Sin 2013; 34:541-8; PMID:23474708; http://dx.doi.org/10.1038/aps.2012.197
   PubMedGoogle Scholar
• Xue H, Lu B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010; 9:545-55; PMID:19924834; http://dx.doi.org/10.1021/pr9008817
   PubMed Web of Science ®Google Scholar
• Li X, Lu Y, Chen Y, Lu W, Xie X. MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples. BMC Cancer 2013; 13:216; PMID:23627607; http://dx.doi.org/10.1186/1471-2407-13-216
   PubMedGoogle Scholar
• Li YL, Ye F, Cheng XD, Hu Y, Zhou CY, Lu WG, Xie X. Identification of glia maturation factor β as an independent prognostic predictor for serous ovarian cancer. Eur J Cancer 2010; 46:2104-18; PMID:20547056; http://dx.doi.org/10.1016/j.ejca.2010.04.015
   PubMed Web of Science ®Google Scholar